{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:21:57Z","timestamp":1789230117143,"version":"build-2803163510"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Severe hypertriglyceridemia causing acute pancreatitis may necessitate intensive care unit (ICU) admission. Management of hypertriglyceridemia in this setting requires therapies that result in rapid triglyceride lowering that are different from therapies used in the outpatient setting. The purpose of this narrative review is to explore strategies for managing hypertriglyceridemia-induced acute pancreatitis (HTGP) in the ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Patients may develop acute pancreatitis when triglyceride levels exceed 500\u2005mg\/dL, either as their primary reason for admission to the ICU or as an adverse effect of medications received during ICU care. Rapid reduction of triglycerides is attained through activation of lipoprotein lipase (LPL), an enzyme essential for the removal of triglycerides from the plasma. Treatment modalities include therapeutic plasma exchange and the combination of insulin and heparin infusions for acute treatment, although there is no consensus on optimal dosing. Fibrates are recommended as first-line agents in prevention of hypertriglyceridemia-induced pancreatitis in high-risk patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Several therapies are used for acute management of HTGP in the ICU setting. Further research is necessary to refine treatment protocols and establish best practices for managing HTGP in critically ill patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf347","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:55:44Z","timestamp":1765976144000},"page":"606-615","source":"Crossref","is-referenced-by-count":1,"title":["Management of hypertriglyceridemia-induced acute pancreatitis in the intensive care unit: A narrative review"],"prefix":"10.1093","volume":"83","author":[{"given":"Erica","family":"Thacker","sequence":"first","affiliation":[{"name":"Research Medical Center , Kansas City, MO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wageh","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center , Harrisburg, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy , Athens, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"2","key":"2026060904142111400_zxaf347-B1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.pan.2021.02.005","article-title":"Hypertriglyceridemia is often under recognized as an aetiologic risk factor for acute pancreatitis: a population-based cohort study","volume":"21","author":"Olesen","year":"2021","journal-title":"Pancreatology"},{"issue":"16","key":"2026060904142111400_zxaf347-B2","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1161\/01.CIR.0000035280.64322.31","article-title":"New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism","volume":"106","author":"Ginsberg","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"2026060904142111400_zxaf347-B3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10 158 Incident cases among 262 525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"2026060904142111400_zxaf347-B4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fendo.2020.00252","article-title":"Causes and consequences of hypertriglyceridemia","volume":"11","author":"Packard","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2026060904142111400_zxaf347-B5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/01.mcg.0000436438.60145.5a","article-title":"Issues in hypertriglyceridemic pancreatitis: an update","volume":"48","author":"Scherer","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"2026060904142111400_zxaf347-B6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/2013.jamainternmed.474","article-title":"Hypertriglyceridemia and acute pancreatitis","volume":"173","author":"Murphy","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"24","key":"2026060904142111400_zxaf347-B7","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2026060904142111400_zxaf347-B8","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"39","key":"2026060904142111400_zxaf347-B9","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"2026060904142111400_zxaf347-B10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.pan.2020.06.005","article-title":"Hypertriglyceridemia and acute pancreatitis","volume":"20","author":"Yang","year":"2020","journal-title":"Pancreatology"},{"issue":"9","key":"2026060904142111400_zxaf347-B11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2026060904142111400_zxaf347-B12","doi-asserted-by":"publisher","first-page":"E825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"3","key":"2026060904142111400_zxaf347-B13","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1097\/CCM.0000000000006574","article-title":"A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"53","author":"Lewis","year":"2025","journal-title":"Crit Care Med"},{"issue":"10 I","key":"2026060904142111400_zxaf347-B14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1592\/phco.2005.25.10.1348","article-title":"Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors","volume":"25","author":"Devlin","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2026060904142111400_zxaf347-B15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1513\/AnnalsATS.202205-403OC","article-title":"Triglyceride concentrations and their relationship to sedation choice and outcomes in mechanically ventilated patients receiving propofol","volume":"20","author":"Pancholi","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"2026060904142111400_zxaf347-B16","doi-asserted-by":"publisher","first-page":"E0330","DOI":"10.1097\/CCE.0000000000000330","article-title":"Evaluation of hypertriglyceridemia in critically ill patients with coronavirus disease 2019 receiving propofol","volume":"3","author":"Kovacevic","year":"2021","journal-title":"Crit Care Explor"},{"key":"2026060904142111400_zxaf347-B17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3165","article-title":"Propofol and clevidipine-induced hypertriglyceridemia","volume":"21","author":"Kaur","year":"2018","journal-title":"Cureus"},{"issue":"4","key":"2026060904142111400_zxaf347-B18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1213\/ane.0b013e31818240db","article-title":"The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients","volume":"107","author":"Aronson","year":"2008","journal-title":"Anesth Analg"},{"key":"2026060904142111400_zxaf347-B19","doi-asserted-by":"publisher","DOI":"10.1177\/10600280241232991","article-title":"Incidence of hypertriglyceridemia in patients on propofol, clevidipine, or both","author":"Johns","journal-title":"Ann Pharmacother"},{"issue":"8078","key":"2026060904142111400_zxaf347-B20","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0140-6736(78)92450-9","article-title":"Treatment of severe diabetic hypertriglyceridaemia by plasma exchange","volume":"1","author":"Betteridge","year":"1978","journal-title":"Lancet"},{"key":"2026060904142111400_zxaf347-B21","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59050864","article-title":"Effect of plasma exchange treatment in patients with hypertriglyceridemia-induced acute pancreatitis","volume":"59(5)","author":"Nguyen","year":"2023","journal-title":"Medicina (Lithuania)"},{"key":"2026060904142111400_zxaf347-B22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jca.21954","article-title":"Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis","volume":"37","author":"Chen","year":"2022","journal-title":"J Clin Apher"},{"issue":"21","key":"2026060904142111400_zxaf347-B23","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.12998\/wjcc.v9.i21.5794","article-title":"Therapeutic plasma exchange for hyperlipidemic pancreatitis: current evidence and unmet needs","volume":"9","author":"Zheng","year":"2021","journal-title":"World J Clin Cases"},{"issue":"6","key":"2026060904142111400_zxaf347-B24","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.transci.2020.102991","article-title":"Urgent therapeutic plasma exchange","volume":"59","author":"Saheb","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"2026060904142111400_zxaf347-B25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1080\/08998280.2022.2106531","article-title":"Plasmapheresis in hypertriglyceridemia-induced acute pancreatitis","volume":"35","author":"Shaka","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"2","key":"2026060904142111400_zxaf347-B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"key":"2026060904142111400_zxaf347-B27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4721357","article-title":"Management of hypertriglyceridemia induced acute pancreatitis","author":"Garg","journal-title":"Biomed Res Int."},{"issue":"1","key":"2026060904142111400_zxaf347-B28","doi-asserted-by":"publisher","first-page":"bvz019","DOI":"10.1210\/jendso\/bvz019","article-title":"Intravenous insulin versus conservative management in hypertriglyceridemia-associated acute pancreatitis","volume":"4","author":"Dhindsa","year":"2019","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026060904142111400_zxaf347-B29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5114\/pg.2014.45412","article-title":"Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin","volume":"10","author":"Coskun","year":"2015","journal-title":"Prz Gastroenterol"},{"issue":"9","key":"2026060904142111400_zxaf347-B30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.35248\/2155-6156.20.11.855","article-title":"Severe hypertriglyceridemia and the risk for acute pancreatitis treated with fluids and rapid insulin in type 2 diabetes and non-diabetic patients","volume":"11","author":"Ahmeti","year":"2020","journal-title":"J Diabetes Metab"},{"issue":"6","key":"2026060904142111400_zxaf347-B31","first-page":"574","article-title":"Intensive insulin therapy in severe acute pancreatitis: a meta-analysis and systematic review","volume":"61","author":"Li","year":"2012","journal-title":"West Indian Med J"},{"issue":"1","key":"2026060904142111400_zxaf347-B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/JP9.0000000000000153","article-title":"Hypertriglyceridemia and acute pancreatitis: clinical and basic research\u2014a narrative review","volume":"7","author":"Gao","year":"2024","journal-title":"J Pancreatol"},{"issue":"1","key":"2026060904142111400_zxaf347-B33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/archinternmed.2009.461","article-title":"Concerns about heparin therapy for hypertriglyceridemia","volume":"170","author":"Whayne","year":"2010","journal-title":"Arch Intern Med"},{"issue":"11","key":"2026060904142111400_zxaf347-B34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.29271\/jcpsp.2021.11.1337","article-title":"Insulin and heparin therapies in acute pancreatitis due to hypertriglyceridemia","volume":"31","author":"Altinkaya","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"issue":"18","key":"2026060904142111400_zxaf347-B35","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3748\/wjg.v13.i18.2642","article-title":"Insulin and heparin in treatment of hypertriglyceridemia-induced pancreatitis","volume":"13","author":"Jain","year":"2007","journal-title":"China World J Gastroenterol"},{"issue":"2","key":"2026060904142111400_zxaf347-B36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1590\/2359-3997000000244","article-title":"Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review","volume":"61","author":"Kuchay","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"2026060904142111400_zxaf347-B37","first-page":"1242","article-title":"Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis","volume":"129","author":"Henzen","year":"1999","journal-title":"Schweiz Med Wochenschr"},{"issue":"6","key":"2026060904142111400_zxaf347-B38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12328-018-0881-1","article-title":"Hypertriglyceridemia-induced pancreatitis: updated review of current treatment and preventive strategies","volume":"11","author":"Rawla","year":"2018","journal-title":"Clin J Gastroenterol"},{"issue":"9","key":"2026060904142111400_zxaf347-B39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/MCG.0000000000000552","article-title":"Emergent triglyceride-lowering therapy with early high volume hemofiltration against low-molecular-weight heparin combined with insulin in hypertriglyceridemic pancreatitis a prospective randomized controlled trial","volume":"50","author":"He","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"2026060904142111400_zxaf347-B40","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/01.cir.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism.","author":"Staels","year":"1998"},{"issue":"02-5215","key":"2026060904142111400_zxaf347-B41","first-page":"3146","article-title":"Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel (III)","author":"Grundy","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"2026060904142111400_zxaf347-B42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2026060904142111400_zxaf347-B43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.14740\/gr762e","article-title":"Acute pancreatitis secondary to severe hypertriglyceridemia: management of severe hypertriglyceridemia in emergency setting","volume":"10","author":"Chaudhary","year":"2017","journal-title":"Gastroenterology Res"},{"key":"2026060904142111400_zxaf347-B44","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38028","article-title":"A case of hypertriglyceridemia-induced acute pancreatitis in the setting of alcohol abuse","author":"Nwaobi","journal-title":"Cureus."},{"key":"2026060904142111400_zxaf347-B45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28273","article-title":"Hypertriglyceridemia-induced acute pancreatitis during pregnancy: a case report","author":"Keller","journal-title":"Cureus."},{"issue":"4","key":"2026060904142111400_zxaf347-B46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4183\/aeb.2019.460","article-title":"Efficacy of insulin, heparin and fenofibrate combination treatment in severe hypertriglyceridemia: double center experience","volume":"15","author":"Ozcelik","year":"2019","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"2026060904142111400_zxaf347-B47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3121\/cmr.2010.898","article-title":"Rapid reduction of severely elevated serum","volume":"9","author":"Poonuru","year":"2011","journal-title":"Clin Med Res"},{"issue":"2","key":"2026060904142111400_zxaf347-B48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.22551\/2023.39.1002.10244","article-title":"Plasmapheresis can correct refractoriness of insulin on triglyceride metabolism \u2013 a case report of hypertriglyceridemia-induced acute pancreatitis","volume":"10","author":"Sundaram","year":"2023","journal-title":"Arch Clin Cases"},{"issue":"20","key":"2026060904142111400_zxaf347-B49","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"25","key":"2026060904142111400_zxaf347-B50","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf347\/66130851\/zxaf347.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/12\/606\/66130851\/zxaf347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/12\/606\/66130851\/zxaf347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:15:27Z","timestamp":1780992927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/12\/606\/8405157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,26]]},"published-print":{"date-parts":[[2026,6,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf347","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,15]]},"published":{"date-parts":[[2025,12,26]]}}}